1. Home
  2. TMDX vs VSEC Comparison

TMDX vs VSEC Comparison

Compare TMDX & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • VSEC
  • Stock Information
  • Founded
  • TMDX 1998
  • VSEC 1959
  • Country
  • TMDX United States
  • VSEC United States
  • Employees
  • TMDX N/A
  • VSEC N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VSEC Military/Government/Technical
  • Sector
  • TMDX Health Care
  • VSEC Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • VSEC Nasdaq
  • Market Cap
  • TMDX 2.3B
  • VSEC 2.7B
  • IPO Year
  • TMDX 2019
  • VSEC N/A
  • Fundamental
  • Price
  • TMDX $123.56
  • VSEC $135.59
  • Analyst Decision
  • TMDX Buy
  • VSEC Strong Buy
  • Analyst Count
  • TMDX 10
  • VSEC 6
  • Target Price
  • TMDX $127.33
  • VSEC $125.17
  • AVG Volume (30 Days)
  • TMDX 830.9K
  • VSEC 191.3K
  • Earning Date
  • TMDX 07-30-2025
  • VSEC 07-30-2025
  • Dividend Yield
  • TMDX N/A
  • VSEC 0.29%
  • EPS Growth
  • TMDX N/A
  • VSEC N/A
  • EPS
  • TMDX 1.41
  • VSEC 0.67
  • Revenue
  • TMDX $488,227,000.00
  • VSEC $1,173,794,000.00
  • Revenue This Year
  • TMDX $34.07
  • VSEC $3.14
  • Revenue Next Year
  • TMDX $20.76
  • VSEC $11.58
  • P/E Ratio
  • TMDX $87.63
  • VSEC $58.11
  • Revenue Growth
  • TMDX 64.43
  • VSEC 40.70
  • 52 Week Low
  • TMDX $55.00
  • VSEC $73.36
  • 52 Week High
  • TMDX $177.37
  • VSEC $140.64
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 45.61
  • VSEC 58.81
  • Support Level
  • TMDX $139.31
  • VSEC $131.33
  • Resistance Level
  • TMDX $145.50
  • VSEC $137.82
  • Average True Range (ATR)
  • TMDX 5.88
  • VSEC 3.82
  • MACD
  • TMDX -2.71
  • VSEC -0.27
  • Stochastic Oscillator
  • TMDX 12.94
  • VSEC 57.85

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

Share on Social Networks: